Primary Record
Dibenzazepine
- In stock
- 2,909 g
- Purity
- 98.2 %
- CAS
- 209984-56-5
Compound Identifiers & Properties
- CAS
- 209984-56-5
- PubChem CID
- 11454028
- SMILES
- C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)CC4=CC(=CC(=C4)F)F
- Canonical SMILES
- C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21
Names & Synonyms
- Dibenzazepine
- 209984-56-5
- Iminostilbene
- YO-01027
- Diben zazepine
- Dibenzazepine;DBZ
- Deshydroxy LY-411575
- GSI-XX
- DBZ (Dibenzazepine)
- Deshydroxy LY 411575
- g-secretase inhibitor XX
- Gamma-secretase inhibitor
- (S)-2-(2-(3,5-Difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
- gamma-Secretase Inhibitor XX
- Deshydroxy LY-411514
- Dibenzazepine (Deshydroxy LY 411575)
- Dibenzazepine (YO-01027)
- |A-Secretase Inhibitor Dbz
- C26H23F2N3O3
- MFCD12828734
- CHEMBL4303400
- cc-425
- MLS006011073
- YO-01027 (Dibenzazepine)
- YO-01027 (Dibenzazepine, DBZ)
- YO-01027(Dibenzazepine)?
- YO01027
- orb1301045
- SCHEMBL3046688
- DTXSID6040458
- SCHEMBL29393672
- YO-01027 (GMP)
- AOB1375
- EX-A027
- QSHGISMANBKLQL-OWJWWREXSA-N
- HMS3884B16
- ANW-62574
- BDBM50533416
- HB3419
- HY-13526G
- s2711
- ZINC22056928
- AKOS016004347
- ACN-038157
- CCG-264984
- CS-6244
- FD21523
- RL02593
- CID11454028
- KS-0000181J
- NCGC00263188-01
- NCGC00263188-03
- NCGC00263188-13
- NCGC00263188-15
- AC-27417
- AJ-80844
- AS-16642
- BC638679
- HY-13526
- SMR004676467
- AB0033830
- DBZ
- TC-151319
- A4018
- CS-0622777
- ST24035862
- SW219340-1
- X7602
- 209984-56-5 pound not YO 01027
- J2.769.996K
- A11174
- Z-3141
- (2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide
- Benzeneacetamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-
- A879305
- BRD-K04622161-001-02-3
- N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide
- Dibenzazepine, 98%, gamma-secretase inhibitor - 5MG 5mg
- (S,S)-2-[2-(3,5-Difluorophenyl)acetylamino]-N-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propionamide
- 256-96-2
- (2S)-2-[2-(3,5-DIFLUOROPHENYL)ACETAMIDO]-N-[(10S)-8-METHYL-9-OXO-8-AZATRICYCLO[9.4.0.0(2),?]PENTADECA-1(15),2(7),3,5,11,13-HEXAEN-10-YL]PROPANAMIDE
- (2S)-2-[2-(3,5-DIFLUOROPHENYL)ACETAMIDO]-N-[(10S)-8-METHYL-9-OXO-8-AZATRICYCLO[9.4.0.0(2),?]PENTADECA-1(15),2,4,6,11,13-HEXAEN-10-YL]PROPANAMIDE
- (2S)-2-[2-(3,5-difluorophenyl)acetamido]-N-[(10S)-8-methyl-9-oxo-8-azatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-10-yl]propanamide
- (2S)-2-[2-(3,5-difluorophenyl)acetamido]-N-[(10S)-8-methyl-9-oxo-8-azatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl]propanamide
- (2S)-2-[2-(3,5-Difluorophenyl)acetylamino]-N-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepine-7-yl]propanamide
- (7S)-5-Methyl-7-[[(2S)-2-[(3,5-difluorophenyl)acetylamino]propanoyl]amino]-5H-dibenzo[b,d]azepine-6(7H)-one
- (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-N-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-propionamide
- (S)-2-[2-(3,5-Difluorophenyl)acetylamino]-N-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepine-7-yl]propanamide
- (S)-N-(5-Methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepine-7beta-yl)-2-[(alpha-oxo-3,5-difluorophenethyl)amino]propanamide
- (S,s)-2-[2-(3,5-difluorophenyl)-acetylamino]-N-(5-methyl-6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl)-propionamide
- DBZ; one of |A-Secretase Inhibitor; (S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
- N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide gamma-Secretase Inhibitor XX
- N-[(1s)-2-[[(7s)-6,7-dihydro-5-methyl-6-oxo-5h-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluro-benzeneacetamide
- N~2~-[(3,5-Difluorophenyl)acetyl]-N-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide